Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Monte Rosa Therapeutics receives FDA clearance for MRT-8102 IND
MRT-8102 is a NEK7-directed molecular glue degrader being developed to treat inflammatory diseases. Credit: National Institute of Allergy and Infectious Diseases by Unsplash.
MRT-8102 is a NEK7-directed molecular glue degrader being developed to treat inflammatory diseases. Credit: National Institute of Allergy and Infectious Diseases by Unsplash.